Search Results

Warnings Regarding Nuclear Cardiac Stress Test Agents Issued By The FDA December 10, 2013 The U.S. Food and Drug Administration (FDA) has issued a warning about health risks that are associated with the use of certain medications given to patients during cardiac nuclear stress tests. The Drug Injury Attorneys with Ferrer, Poirot & Wansbrough explain officials have stated patients who are given dosages of Lexiscan (regadenoson) (more...)